WO2022139739A2 - Composition having a ph value compatible with ideal ph value of skin and skin product in which said composition is applied - Google Patents
Composition having a ph value compatible with ideal ph value of skin and skin product in which said composition is applied Download PDFInfo
- Publication number
- WO2022139739A2 WO2022139739A2 PCT/TR2021/051254 TR2021051254W WO2022139739A2 WO 2022139739 A2 WO2022139739 A2 WO 2022139739A2 TR 2021051254 W TR2021051254 W TR 2021051254W WO 2022139739 A2 WO2022139739 A2 WO 2022139739A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- skin
- weight
- composition
- ratio
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000003755 preservative agent Substances 0.000 claims abstract description 36
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 15
- 244000005700 microbiome Species 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 18
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical group CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 18
- 239000002253 acid Substances 0.000 claims description 13
- 230000000694 effects Effects 0.000 claims description 5
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims description 3
- KMPHTYSTEHXSTL-UHFFFAOYSA-M sodium;2-hydroxypropanoate;2-hydroxypropanoic acid Chemical compound [Na+].CC(O)C(O)=O.CC(O)C([O-])=O KMPHTYSTEHXSTL-UHFFFAOYSA-M 0.000 claims description 3
- XPFJYKARVSSRHE-UHFFFAOYSA-K trisodium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].[Na+].[Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XPFJYKARVSSRHE-UHFFFAOYSA-K 0.000 claims description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical group C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Natural products CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical group CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical group C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical group [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000001632 sodium acetate Substances 0.000 claims 1
- 235000017281 sodium acetate Nutrition 0.000 claims 1
- 239000001509 sodium citrate Substances 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical group O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- 239000001540 sodium lactate Substances 0.000 claims 1
- 229940005581 sodium lactate Drugs 0.000 claims 1
- 235000011088 sodium lactate Nutrition 0.000 claims 1
- 230000008591 skin barrier function Effects 0.000 abstract description 9
- 230000002829 reductive effect Effects 0.000 abstract description 5
- 230000009467 reduction Effects 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 description 7
- 239000004745 nonwoven fabric Substances 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000005808 skin problem Effects 0.000 description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000036559 skin health Effects 0.000 description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920001090 Polyaminopropyl biguanide Polymers 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- DMSMPAJRVJJAGA-UHFFFAOYSA-N benzo[d]isothiazol-3-one Chemical compound C1=CC=C2C(=O)NSC2=C1 DMSMPAJRVJJAGA-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000002925 chemical effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- SOROIESOUPGGFO-UHFFFAOYSA-N diazolidinylurea Chemical compound OCNC(=O)N(CO)C1N(CO)C(=O)N(CO)C1=O SOROIESOUPGGFO-UHFFFAOYSA-N 0.000 description 1
- 229960001083 diazolidinylurea Drugs 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 229940093424 polyaminopropyl biguanide Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
Definitions
- the subject of the invention relates to a composition enabling the skin to be cleansed by preserving the natural balance of the skin and without damaging the skin barrier and having a pH value compatible with the ideal pH value of the skin, wherein the number and concentrations of preservative agents employed in the products according to the state of the art are reduced owing to the reduction of the potential for the growth of microorganisms, and to a skin product in which said composition is applied.
- the skin surface is the part of the body that is in continuous contact with the external environment and in interaction with numerous environmental factors and is thus exposed to numerous microbial agents in the environments contacted.
- the skin is the part of the body that protects the internal organs from the external mechanical, chemical and biological effects by separating the same from the external environment, assists with the regulation of the body temperature and water balance and is capable of self-repair by performing the production of collagen and protein. Therefore, it is of importance to cleanse the skin by the use of skin products compatible with the pH value of the skin surface and without disrupting the skin barrier.
- the need to clean our hands or face is today commonly satisfied still by the use of wet wipes.
- the wet wipes are required to cleanse the skin without damaging the skin surface where they contact and by protecting the natural skin barrier and to provide the proper conditions of hygiene. Because of their practical use, the wet wipes are today frequently used in the restaurants, schools and even in hospitals, on the surfaces as well as on various body parts such as hands, face, etc. for the purposes of cleaning and hygiene. Because of their practical use, the mothers also make use of the wet wipes for cleansing the skin of their babies.
- the wet wipes being used are expected to cleanse the skin surface and achieve the hygienic conditions while at the same time preserving the skin barrier and the moisture balance of the skin and having a pH value suitable for the protection of the skin health.
- the microorganisms such as yeast fungi, etc. are known to have a high growth potential on the skin in an environment of high pH (6-6.5).
- an environment of low pH assists in the reinforcement of the natural barrier layer of the skin by supporting the production of ceramide, one of the basic constituents of the skin. Therefore, the pH of the skin is desired to lie in the range of 4-4.5.
- the pH value of the wet wipes intended for skin cleansing has become a need and has become even more widespread especially in the periods of disease and epidemics, to be compatible with the pH value of the skin.
- the pH value of the wet wipes used according to the state of the art is in the range of 5.5-6, which fails to satisfy the mentioned need, and the frequent use of the wet wipes with such pH range especially in the presence of an epidemic or disease leads to the skin problems.
- the wet wipes are obtained by way of impregnation of the nonwoven fabrics with a solution having generally high water content.
- a nonwoven fabric is subjected to treatment with a solution with high water content, more than one preservative agent (hexamidine diisethionate, methylisothiazolinone, benzisothiazolinone, imidazolidinyl urea, diazolidinyl urea, polyaminopropyl biguanide, DMDMH, etc.) with the possibility of providing action against different microorganisms (bacteria, mould, yeast) are added to the wet wipe formulations usually at high ratios such that no microbiological growth occurs.
- preservative agent hexamidine diisethionate, methylisothiazolinone, benzisothiazolinone, imidazolidinyl urea, diazolidinyl urea, polyaminopropyl biguanide, DMDMH, etc.
- Another problem encountered in the state of the art is the necessity to use greater number preservative agents at higher concentrations in the products having a high pH value (5.5-6) in order to protect such products microbiologically.
- a nonwoven fabric is treated with a solution/composition, differences are observed in the pH values of the finished products due to the components transferred from the fabric to the solution. Accordingly, stabilizing the pH values of the employed solutions/compositions is a further problem encountered in the state of the art that needs to be solved.
- the invention is aimed to develop a skin care product with a lower potential for the growth of microorganisms owing to having a lower and more stable pH value as compared to the existing products, in an effort to provide a solution for the mentioned problems.
- the potential for the growth of microorganisms will be reduced in the product owing to the low pH value, it will be possible to cleanse the skin with a skin product compatible with the pH value of the skin, and further, the use of a smaller number of preservatives at lower concentrations will be possible as a result of the low pH value.
- compositions comprising a smaller number of preservative agents at lower concentrations and having a pH value compatible with the pH value of the skin and a skin product in which said composition is applied have been developed within the scope of the invention.
- Table 1 Minimum inhibitory concentration value of pentylene glycol in the pH environment of the composition developed within the scope of the invention and minimum inhibitory concentration value of pentylene glycol stated in the literature
- An object of the invention is to develop a composition having a pH value compatible with the pH value of the skin.
- Another object of the invention is to develop a skin product, which is to be used in cleansing the skin surface and which is to enable the development of the hygienic conditions ideal for the skin by preserving the skin barrier and by having a pH value compatible with the pH value of the skin.
- Another object of the invention is to develop a skin care product wherein the potential for the growth of microorganisms is reduced owing to a pH value of about 3-4.5 and the conditions favorable in terms of hygiene are provided.
- Another object of the invention is to develop a wet wipe as the skin care product.
- the subject of the invention relates to a composition enabling the skin to be cleansed by preserving the natural balance of the skin and without damaging the skin barrier and having a pH value compatible with the ideal pH value of the skin, wherein the number and concentrations of preservative agents employed in the products according to the state of the art are reduced owing to the reduction of the potential for the growth of microorganisms, and to a skin product in which said composition is applied.
- the skin products currently in use generally contain more than one preservative agent in high concentrations in order to provide microbiological protection for said products.
- These preservatives used in the skin products cause the irritation of the skin and increased water loss from the skin due to the disruption of the skin barrier.
- the disruption of the moisture balance of the skin and of the barrier layer that protects the skin provides a favorable environment for sheltering the components that irritate the skin and the pathogenic microorganisms desired to be removed from the skin surface. This leads to the development of allergic reactions in the skin.
- a low pH assists in the reinforcement of the natural barrier layer of the skin by supporting the production of ceramide, one of the basic constituents of the skin. It is not possible to keep the pH values of the products currently in use at such acidity levels. When the pH value of the finished products fails to provide sufficient acidity, it becomes necessary to employ higher ratios of preservative agents in order to achieve a microbiologically effective protection. In that case, the natural balance of the skin becomes disrupted, and instead of providing the hygienically appropriate conditions, the skin is rendered an environment favorable as a host for the microorganisms.
- compositions having a pH value compatible with the pH of the skin wherein the pH variation is minimized and a skin product in which said composition is applied have been developed within the scope of the invention.
- composition developed within the scope of the invention comprises water, at least one preservative agent with increased activity against the microorganisms in a low pH range compatible with the pH value of the skin, preferably in the pH range of 3-4.5, and at least one pH-regulating agent that enables the ambient pH to be stable.
- composition according to the invention preferably comprises a buffer pair containing at least one acid and the conjugate base of the acid as the pH-regulating agent.
- pentylene glycol is preferably used as the preservative agent. It was found out that the activity of pentylene glycol increases with decreasing ambient pH value (3-4.5). Based on the results of the minimum inhibitory concentration (MIC) test conducted, it was determined that pentylene glycol was effective against different microorganisms at these pH values.
- the minimum inhibitory concentration (MIC) of pentylene glycol that is stated in the literature to be effective against the microorganisms is higher than the ratio used within the scope of the invention.
- the minimum inhibitory concentrations stated in the literature and the concentration of pentylene glycol required to be used in an environment of low pH value developed within the scope of the invention are shown in Table 1 below.
- Table 1 Minimum inhibitory concentration value of pentylene glycol in the pH environment of the composition developed within the scope of the invention and minimum inhibitory concentration value of pentylene glycol stated in the literature
- composition developed within the scope of the invention comprises 85-91% by weight water, 2-4% by weight at least one pH-regulating agent and 1-5% by weight at least one preservative agent.
- the use of at least one of citric acid-sodium citrate conjugated acid-base pair, lactic acid-sodium lactate conjugated acid-base pair and acetic acid-sodium acetate conjugated acid-base pair is preferred as the pH-regulating agent.
- At least one conjugated acid-base pair containing 1-2% by weight at least one acid and 1-2% by weight conjugate base of the acid used is employed as the pH-regulating agent.
- a preferred embodiment of the invention comprises pentylene glycol as the preservative agent and citric acid-sodium citrate conjugated acid-base pair as the pH-regulating agent.
- Another preferred embodiment of the invention comprises pentylene glycol as the preservative agent and lactic acid-sodium lactate conjugated acid-base pair as the pH- regulating agent.
- Another preferred embodiment of the invention comprises pentylene glycol as the preservative agent and acetic acid-sodium acetate conjugated acid-base pair as the pH- regulating agent.
- pentylene glycol is used at a ratio of 1-1.5% by weight as the preservative agent.
- pentylene glycol is used at a ratio of 1.5-2% by weight as the preservative agent. In a preferred embodiment of the composition developed within the scope of the invention, pentylene glycol is used at a ratio of 2-2.5% by weight as the preservative agent.
- pentylene glycol is used at a ratio of 2.5-3% by weight as the preservative agent.
- the subject of the invention also relates to a skin product in which the composition according to the invention is applied.
- the skin product developed within the scope of the invention is preferably a wet wipe.
- the skin product according to the invention is obtained by way of application of the composition according to the invention to a nonwoven fabric. After the wet wipe compositions are prepared, the nonwoven fabrics are subjected to treatment with the compositions in order to obtain the skin product.
- the weight of one piece of dry tissue is determined by performing calculations based on a nonwoven fabric with known dimensions (width and length) and weight (g/m2). How much composition is to be transferred to one piece of dry tissue is determined according to the wetting factor and the skin product is obtained by impregnating the dry product with the composition according to the invention under the appropriate conditions.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
The subject of the invention relates to a composition enabling the skin to be cleansed by preserving the natural balance of the skin and without damaging the skin barrier and having a pH value compatible with the ideal pH value of the skin, wherein the number and concentrations of preservative agents employed in the products according to the state of the art are reduced owing to the reduction of the potential for the growth of microorganisms, and to a skin product in which said composition is applied. The composition developed within the scope of the invention comprises 85-91% by weight water, 2-4% by weight at least one pH-regulating agent and 1-5% by weight at least one preservative agent.
Description
COMPOSITION HAVING A pH VALUE COMPATIBLE WITH IDEAL pH VALUE OF SKIN AND SKIN PRODUCT IN WHICH SAID COMPOSITION IS APPLIED
Subject of the Invention
The subject of the invention relates to a composition enabling the skin to be cleansed by preserving the natural balance of the skin and without damaging the skin barrier and having a pH value compatible with the ideal pH value of the skin, wherein the number and concentrations of preservative agents employed in the products according to the state of the art are reduced owing to the reduction of the potential for the growth of microorganisms, and to a skin product in which said composition is applied.
State of the Art
The skin surface is the part of the body that is in continuous contact with the external environment and in interaction with numerous environmental factors and is thus exposed to numerous microbial agents in the environments contacted. Besides, the skin is the part of the body that protects the internal organs from the external mechanical, chemical and biological effects by separating the same from the external environment, assists with the regulation of the body temperature and water balance and is capable of self-repair by performing the production of collagen and protein. Therefore, it is of importance to cleanse the skin by the use of skin products compatible with the pH value of the skin surface and without disrupting the skin barrier.
In the ambiences such as travel ambience where to make use of water is not immediately possible or in the ambiences such as public transport where the hygienic conditions are not appropriate, the need to clean our hands or face is today commonly satisfied still by the use of wet wipes. The wet wipes, the use of which has become quite widespread, are required to cleanse the skin without damaging the skin surface where they contact and by protecting the natural skin barrier and to provide the proper conditions of hygiene. Because of their practical use, the wet wipes are today frequently used in the restaurants, schools and even in hospitals, on the surfaces as well as on various body parts such as hands, face, etc. for the purposes of cleaning and hygiene. Because of their practical use, the mothers also make use of the wet wipes for cleansing the skin of their babies.
The wet wipes being used are expected to cleanse the skin surface and achieve the hygienic conditions while at the same time preserving the skin barrier and the moisture balance of the skin and having a pH value suitable for the protection of the skin health. The microorganisms such as yeast fungi, etc. are known to have a high growth potential on the skin in an environment of high pH (6-6.5). On the other hand, an environment of low pH assists in the reinforcement of the natural barrier layer of the skin by supporting the production of ceramide, one of the basic constituents of the skin. Therefore, the pH of the
skin is desired to lie in the range of 4-4.5. Likewise, it has become a significant necessity for the pH value of the wet wipes intended for skin cleansing, the use of which has become a need and has become even more widespread especially in the periods of disease and epidemics, to be compatible with the pH value of the skin. In this way, it would be possible to cleanse the skin without the development of skin problems such as infection, irritation and rash, etc. by preventing the growth of the yeast fungi such as Candida Albicans and other microorganisms and without increasing the pH value of the skin. However, the pH value of the wet wipes used according to the state of the art is in the range of 5.5-6, which fails to satisfy the mentioned need, and the frequent use of the wet wipes with such pH range especially in the presence of an epidemic or disease leads to the skin problems.
The wet wipes are obtained by way of impregnation of the nonwoven fabrics with a solution having generally high water content. When a nonwoven fabric is subjected to treatment with a solution with high water content, more than one preservative agent (hexamidine diisethionate, methylisothiazolinone, benzisothiazolinone, imidazolidinyl urea, diazolidinyl urea, polyaminopropyl biguanide, DMDMH, etc.) with the possibility of providing action against different microorganisms (bacteria, mould, yeast) are added to the wet wipe formulations usually at high ratios such that no microbiological growth occurs. However, when the products according to the state of the art are used, the skin irritation occurs and the skin problems on the skin surface, such as rash, etc., emerge especially in the babies having a thinner and more sensitive skin than the adult skin, depending on the concentrations and types of the preservatives such products contain.
Another problem encountered in the state of the art is the necessity to use greater number preservative agents at higher concentrations in the products having a high pH value (5.5-6) in order to protect such products microbiologically. Moreover, when a nonwoven fabric is treated with a solution/composition, differences are observed in the pH values of the finished products due to the components transferred from the fabric to the solution. Accordingly, stabilizing the pH values of the employed solutions/compositions is a further problem encountered in the state of the art that needs to be solved.
Within the scope of the invention, it is aimed to develop a skin care product with a lower potential for the growth of microorganisms owing to having a lower and more stable pH value as compared to the existing products, in an effort to provide a solution for the mentioned problems. By this means, the potential for the growth of microorganisms will be reduced in the product owing to the low pH value, it will be possible to cleanse the skin with a skin product compatible with the pH value of the skin, and further, the use of a smaller number of preservatives at lower concentrations will be possible as a result of the low pH value.
In order to satisfy the mentioned need and resolve the above-mentioned problems of the state of the art, a composition comprising a smaller number of preservative agents at lower concentrations and having a pH value compatible with the pH value of the skin and a skin
product in which said composition is applied have been developed within the scope of the invention.
Description of the Tables
Table 1: Minimum inhibitory concentration value of pentylene glycol in the pH environment of the composition developed within the scope of the invention and minimum inhibitory concentration value of pentylene glycol stated in the literature
Object of the Invention
An object of the invention is to develop a composition having a pH value compatible with the pH value of the skin.
Another object of the invention is to develop a skin product, which is to be used in cleansing the skin surface and which is to enable the development of the hygienic conditions ideal for the skin by preserving the skin barrier and by having a pH value compatible with the pH value of the skin.
Another object of the invention is to develop a skin care product wherein the potential for the growth of microorganisms is reduced owing to a pH value of about 3-4.5 and the conditions favorable in terms of hygiene are provided.
Another object of the invention is to develop a wet wipe as the skin care product.
Description of the Invention
The subject of the invention relates to a composition enabling the skin to be cleansed by preserving the natural balance of the skin and without damaging the skin barrier and having a pH value compatible with the ideal pH value of the skin, wherein the number and concentrations of preservative agents employed in the products according to the state of the art are reduced owing to the reduction of the potential for the growth of microorganisms, and to a skin product in which said composition is applied.
The skin products currently in use generally contain more than one preservative agent in high concentrations in order to provide microbiological protection for said products. These preservatives used in the skin products cause the irritation of the skin and increased water loss from the skin due to the disruption of the skin barrier. The disruption of the moisture balance of the skin and of the barrier layer that protects the skin provides a favorable environment for sheltering the components that irritate the skin and the pathogenic microorganisms desired to be removed from the skin surface. This leads to the development of allergic reactions in the skin.
A low pH assists in the reinforcement of the natural barrier layer of the skin by supporting the production of ceramide, one of the basic constituents of the skin. It is not possible to keep the pH values of the products currently in use at such acidity levels. When the pH value
of the finished products fails to provide sufficient acidity, it becomes necessary to employ higher ratios of preservative agents in order to achieve a microbiologically effective protection. In that case, the natural balance of the skin becomes disrupted, and instead of providing the hygienically appropriate conditions, the skin is rendered an environment favorable as a host for the microorganisms. In addition, when a nonwoven fabric is treated with a solution/composition in order to obtain the skin products, the differences are observed in the pH values of the finished products due to the components transferred from the fabric to the solution. Accordingly, it is necessary to minimize the pH variation in the composition.
In order to provide a solution for the mentioned problems, a composition having a pH value compatible with the pH of the skin wherein the pH variation is minimized and a skin product in which said composition is applied have been developed within the scope of the invention.
The composition developed within the scope of the invention comprises water, at least one preservative agent with increased activity against the microorganisms in a low pH range compatible with the pH value of the skin, preferably in the pH range of 3-4.5, and at least one pH-regulating agent that enables the ambient pH to be stable.
The composition according to the invention preferably comprises a buffer pair containing at least one acid and the conjugate base of the acid as the pH-regulating agent.
Within the scope of the invention, pentylene glycol is preferably used as the preservative agent. It was found out that the activity of pentylene glycol increases with decreasing ambient pH value (3-4.5). Based on the results of the minimum inhibitory concentration (MIC) test conducted, it was determined that pentylene glycol was effective against different microorganisms at these pH values. The minimum inhibitory concentration (MIC) of pentylene glycol that is stated in the literature to be effective against the microorganisms is higher than the ratio used within the scope of the invention. The minimum inhibitory concentrations stated in the literature and the concentration of pentylene glycol required to be used in an environment of low pH value developed within the scope of the invention are shown in Table 1 below.
Table 1: Minimum inhibitory concentration value of pentylene glycol in the pH environment of the composition developed within the scope of the invention and minimum inhibitory concentration value of pentylene glycol stated in the literature
The composition developed within the scope of the invention comprises 85-91% by weight water, 2-4% by weight at least one pH-regulating agent and 1-5% by weight at least one preservative agent.
Within the scope of the invention, the use of at least one of citric acid-sodium citrate conjugated acid-base pair, lactic acid-sodium lactate conjugated acid-base pair and acetic acid-sodium acetate conjugated acid-base pair is preferred as the pH-regulating agent.
In a preferred embodiment of the invention, at least one conjugated acid-base pair containing 1-2% by weight at least one acid and 1-2% by weight conjugate base of the acid used is employed as the pH-regulating agent.
A preferred embodiment of the invention comprises pentylene glycol as the preservative agent and citric acid-sodium citrate conjugated acid-base pair as the pH-regulating agent.
Another preferred embodiment of the invention comprises pentylene glycol as the preservative agent and lactic acid-sodium lactate conjugated acid-base pair as the pH- regulating agent.
Another preferred embodiment of the invention comprises pentylene glycol as the preservative agent and acetic acid-sodium acetate conjugated acid-base pair as the pH- regulating agent.
In a preferred embodiment of the composition developed within the scope of the invention, pentylene glycol is used at a ratio of 1-1.5% by weight as the preservative agent.
In a preferred embodiment of the composition developed within the scope of the invention, pentylene glycol is used at a ratio of 1.5-2% by weight as the preservative agent.
In a preferred embodiment of the composition developed within the scope of the invention, pentylene glycol is used at a ratio of 2-2.5% by weight as the preservative agent.
In a preferred embodiment of the composition developed within the scope of the invention, pentylene glycol is used at a ratio of 2.5-3% by weight as the preservative agent.
The subject of the invention also relates to a skin product in which the composition according to the invention is applied. The skin product developed within the scope of the invention is preferably a wet wipe. The skin product according to the invention is obtained by way of application of the composition according to the invention to a nonwoven fabric. After the wet wipe compositions are prepared, the nonwoven fabrics are subjected to treatment with the compositions in order to obtain the skin product. The weight of one piece of dry tissue is determined by performing calculations based on a nonwoven fabric with known dimensions (width and length) and weight (g/m2). How much composition is to be transferred to one piece of dry tissue is determined according to the wetting factor and the skin product is obtained by impregnating the dry product with the composition according to the invention under the appropriate conditions.
Owing to the composition developed within the scope of the invention and the skin product in which said composition is applied, it is made possible to cleanse the skin by preserving the moisture balance of the skin and the skin barrier and without increasing the pH value of the skin, as a result of the pH value of the composition being stable and compatible with the pH of the skin, and further, the adverse effects of the existing products on the skin health are eliminated since the product according to the invention does not contain any additional preservative agent, owing to said product's content of preservative agent with increased activity against the microorganisms at low pH values (3-4.5).
Claims
1. A composition having a pH value that is stable and compatible with the pH of the skin characterized in that the composition comprises
• water,
• at least one pH-regulating agent containing a pair formed by at least one acid and the conjugate base of the acid such that the pH value is stable in the range of 3-4.5, and
• at least one preservative agent with activity against the microorganisms in said pH range of 3-4.5.
2. A composition according to Claim 1 characterized in that said preservative agent is pentylene glycol.
3. Composition according to Claim 1 or Claim 2 characterized in that the composition comprises said preservative agent at a ratio of 1-5% by weight.
4. Composition according to Claim 1 or Claim 2 characterized in that the composition comprises said preservative agent at a ratio of 1-1.5% by weight.
5. Composition according to Claim 1 or Claim 2 characterized in that the composition comprises said preservative agent at a ratio of 1.5-2% by weight.
6. Composition according to Claim 1 or Claim 2 characterized in that the composition comprises said preservative agent at a ratio of 2-2.5% by weight.
7. Composition according to Claim 1 or Claim 2 characterized in that the composition comprises said preservative agent at a ratio of 2.5-3% by weight.
8. Composition according to any one of preceding claims characterized in that the composition comprises said pH-regulating agent at a ratio of 2-4% by weight.
9. Composition according to Claim 1 or Claim 8 characterized in that the composition comprises as said pH-regulating agent at least one conjugated acid-base pair containing 1- 2% by weight at least one acid and 1-2% by weight conjugate base of the acid used.
10. Composition according to Claim 1 or Claim 9 characterized in that said pH-regulating agent is at least one of citric acid-sodium citrate conjugated acid-base pair, lactic acid- sodium lactate conjugated acid-base pair and acetic acid-sodium acetate conjugated acidbase pair.
11. Composition according to claim 1 characterized in that the composition comprises
• 85-91% by weight water,
• at least one acid at a ratio of 1-2% by weight and conjugate base of the acid at a ratio of 1-2% by weight as the pH-regulating agent, and
7
pentylene glycol as the preservative agent.
12. Composition according to Claim 11 characterized in that said acid at a ratio of 1-2% by weight is citric acid and said base used at a ratio of 1-2% by weight is sodium citrate.
13. Composition according to Claim 11 characterized in that said acid at a ratio of 1-2% by weight is lactic acid and said base used at a ratio of 1-2% by weight is sodium lactate.
14. Composition according to Claim 11 characterized in that said acid at a ratio of 1-2% by weight is acetic acid and said base used at a ratio of 1-2% by weight is sodium acetate.
15. A composition according to any one of Claims 11-14 characterized in that the composition comprises said preservative agent at a ratio of 1-1.5% by weight.
16. A composition according to any one of Claims 11-14 characterized in that the composition comprises said preservative agent at a ratio of 1.5-2% by weight.
17. A composition according to any one of Claims 11-14 characterized in that the composition comprises said preservative agent at a ratio of 2-2.5% by weight.
18. A composition according to any one of Claims 11-14 characterized in that the composition comprises said preservative agent at a ratio of 2.5-3% by weight.
19. A skin product characterized in that the skin product comprises a composition according to any one of the preceding claims.
20. A skin product according to Claim 19 characterized in that the skin product is a wet wipe.
21. A skin product according to Claim 20 characterized in that the skin product has a pH value in the range of 3-4.5.
8
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2020/20998A TR202020998A2 (en) | 2020-12-21 | 2020-12-21 | A COMPOSITION WITH A pH VALUE COMPATIBLE WITH THE IDEAL SKIN pH VALUE AND A SKIN PRODUCT WHICH IS APPLIED TO THIS COMPOSITION |
TR2020/20998 | 2020-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2022139739A2 true WO2022139739A2 (en) | 2022-06-30 |
WO2022139739A3 WO2022139739A3 (en) | 2022-08-11 |
Family
ID=82160022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/TR2021/051254 WO2022139739A2 (en) | 2020-12-21 | 2021-11-22 | Composition having a ph value compatible with ideal ph value of skin and skin product in which said composition is applied |
Country Status (2)
Country | Link |
---|---|
TR (1) | TR202020998A2 (en) |
WO (1) | WO2022139739A2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6828136B2 (en) * | 2016-10-11 | 2021-02-10 | シムライズ アーゲー | Antibacterial composition |
KR102026810B1 (en) * | 2017-12-12 | 2019-09-30 | 주식회사 크로파세 | A preservative for skin external application, and a cosmetic composition and a pharmaceutical composition comprising the same |
CN108014032A (en) * | 2018-01-02 | 2018-05-11 | 深圳市芭格美生物科技有限公司 | A kind of hip pad wet tissue and preparation method thereof |
-
2020
- 2020-12-21 TR TR2020/20998A patent/TR202020998A2/en unknown
-
2021
- 2021-11-22 WO PCT/TR2021/051254 patent/WO2022139739A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022139739A3 (en) | 2022-08-11 |
TR202020998A2 (en) | 2022-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lowbury et al. | Preoperative disinfection of surgeons' hands: use of alcoholic solutions and effects of gloves on skin flora | |
CA2084730C (en) | Skin antiseptic and hand disinfectant | |
Ayliffe | Surgical scrub and skin disinfection | |
US4045364A (en) | Iodophor soap tissues | |
JP4681693B2 (en) | Food disinfectant | |
JPH11113780A (en) | Sterile wet tissue | |
CN108186403A (en) | A kind of impregnated wipe and preparation method thereof | |
Laufman | Current use of skin and wound cleansers and antiseptics | |
US20060199791A1 (en) | Anti-microbial composition comprising a metal ion chelating agent | |
JPH0816042B2 (en) | Liquid for contact lenses | |
CN1093134A (en) | Sanitary wet towel for baby | |
JP2000273492A (en) | Cleaning agent composition and cleaning goods impregnated with the same | |
Lilly et al. | Disinfection of the skin with detergent preparations of Irgasan DP 300 and other antiseptics | |
JPH11113779A (en) | Sterile wet tissue | |
WO2022139739A2 (en) | Composition having a ph value compatible with ideal ph value of skin and skin product in which said composition is applied | |
JP3996215B2 (en) | Disinfecting composition | |
US4885310A (en) | Anti-fungal methods and agent | |
JPH10324624A (en) | Bactericidal disinfectant composition | |
JPH072615A (en) | Cloth impregnated with antimicrobial disinfectant | |
CN114376933A (en) | Antimicrobial composition for infant hand and mouth wet tissue and preparation method thereof | |
JPS6357502A (en) | Antiseptic composition for finger | |
AU2003248583A1 (en) | Food-grade sanitizing composition | |
JP2893177B2 (en) | Ethanol formulation composition | |
WO2004112765A1 (en) | Method for inhibiting the growth of antibiotic-resistant of bacteria by using pentane-1,5-diol | |
JP2004159742A (en) | Sanitized cotton |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21911719 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21911719 Country of ref document: EP Kind code of ref document: A2 |